Acute pulmonary thromboembolism occurring during treatment with tolvaptan in a patient with autosomal-dominant polycystic kidney disease

Autosomal-dominant polycystic kidney disease (ADPKD) is the most prevalent cystic kidney disease, with approximately half of the patients reaching end-stage renal disease by the age of 60. Tolvaptan prevents renal cyst growth by inhibiting intracellular cyclic AMP and is recommended for patients wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CEN Case Rep
Egile Nagusiak: Morimoto, Katsuhiko, Akai, Yasuhiro, Matsui, Masaru, Yano, Hiroki, Tagawa, Miho, Samejima, Ken-ichi, Saito, Yoshihiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Japan 2017
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438809/
https://ncbi.nlm.nih.gov/pubmed/28509130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-016-0245-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak